source
- A CAR-T biotech’s dramatic turnaround, and drugmakers’ tactics to drive more scriptsThis week on "The Readout LOUD": a CAR-T biotech's dramatic turnaround, and drugmakers' tactics to drive more scripts. Listen now.STAT · 4mo ago↗ source
- STAT+: Trump celebrates closing first round of drug pricing deals, promises more aheadA deal with Regeneron was the last of 17 initially sought by the White House.STAT · 4mo ago↗ source
- FDA approves Regeneron's hearing loss gene therapy OtarmeniRegeneron has won the first-ever FDA approval for a gene therapy to treat a rare type of inherited hearing loss, and the company plans to offer the treatment for free in the US, though that ...Endpoints · 4mo ago↗ source